Search - tctmd.com

Displaying 301 - 320 of 336

Sort: Relevancy | Date

Presentation TCT 2014

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

Presenter: Roxana Mehran, Mohamed Sobhy, Habib Gamra

September 13, 2014

Presentation TCT 2014

Left Main Disease: Practical Issues When Determining Treatment

Presenter: Roxana Mehran, Mohamed Sobhy, Gennaro Sardella

September 13, 2014

Presentation TCT 2014

Intermediate Syntax Score: PCI vs CABG?

Presenter: Roxana Mehran, Mohamed Sobhy, Davide Capodanno

September 13, 2014

Presentation TCT 2014

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Presenter: Roxana Mehran, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

How I Treated My Patient

Presenter: Srihari S. Naidu

September 13, 2014

Presentation TCT 2014

Put Your Ego Aside: Prophylactic Use Avoids Procedural Catastrophes and Improves Late Outcomes and Should be Used in This Case!

Presenter: David X. Zhao

September 13, 2014

Presentation TCT 2014

Prophylactic Hemodynamic Support is Expensive, Causes Complications, and Is Rarely Required in High-Risk PCI. Not in This Case!

Presenter: Antonio Colombo

September 13, 2014

Presentation TCT 2014

Case Presentation Setting the Stage: Should Prophylactic Hemodynamic Support Be Used?

Presenter: Srihari S. Naidu

September 13, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Conference News TCT 2013

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

October 31, 2013

Presentation TCT 2013

Navigating a Rocky Crossing - PCI for Complex Calcific Disease in a High Risk Patient

Presenter: Nigel Jepson

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Conference News TCT 2012

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

October 25, 2012

News Conference News TCT 2012

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

October 25, 2012

News Conference News TCT 2012

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

October 24, 2012

News Conference News TCT 2012

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

October 24, 2012

Advertisement

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

Left Main Disease: Practical Issues When Determining Treatment

Intermediate Syntax Score: PCI vs CABG?

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

How I Treated My Patient

Put Your Ego Aside: Prophylactic Use Avoids Procedural Catastrophes and Improves Late Outcomes and Should be Used in This Case!

Prophylactic Hemodynamic Support is Expensive, Causes Complications, and Is Rarely Required in High-Risk PCI. Not in This Case!

Case Presentation Setting the Stage: Should Prophylactic Hemodynamic Support Be Used?

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

OPTIMIZE: 3-Month DAPT Safe with ZES

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

Navigating a Rocky Crossing - PCI for Complex Calcific Disease in a High Risk Patient

Two Trials to Assess TAVR in Moderate-Risk Patients

Cre8, BioFreedom Polymer-Free DES Show Promise

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content